chr6-116792561-T-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_148963.4(GPRC6A):āc.2362A>Cā(p.Met788Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000156 in 1,612,326 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000092 ( 0 hom., cov: 33)
Exomes š: 0.00016 ( 0 hom. )
Consequence
GPRC6A
NM_148963.4 missense
NM_148963.4 missense
Scores
8
11
Clinical Significance
Conservation
PhyloP100: 4.86
Genes affected
GPRC6A (HGNC:18510): (G protein-coupled receptor class C group 6 member A) Members of family C of the G protein-coupled receptor (GPCR) superfamily, such as GPRC6A, are characterized by an evolutionarily conserved amino acid-sensing motif linked to an intramembranous 7-transmembrane loop region. Several members of GPCR family C, including GPRC6A, also have a long N-terminal domain (summary by Pi et al., 2005 [PubMed 16199532]).[supplied by OMIM, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.38610828).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPRC6A | NM_148963.4 | c.2362A>C | p.Met788Leu | missense_variant | 6/6 | ENST00000310357.8 | |
GPRC6A | NM_001286355.1 | c.2149A>C | p.Met717Leu | missense_variant | 5/5 | ||
GPRC6A | NM_001286354.1 | c.1837A>C | p.Met613Leu | missense_variant | 6/6 | ||
GPRC6A | XM_017010475.2 | c.2221A>C | p.Met741Leu | missense_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPRC6A | ENST00000310357.8 | c.2362A>C | p.Met788Leu | missense_variant | 6/6 | 1 | NM_148963.4 | P1 | |
GPRC6A | ENST00000368549.7 | c.2149A>C | p.Met717Leu | missense_variant | 5/5 | 1 | |||
GPRC6A | ENST00000530250.1 | c.1837A>C | p.Met613Leu | missense_variant | 6/6 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 152054Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
14
AN:
152054
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000687 AC: 17AN: 247454Hom.: 0 AF XY: 0.0000523 AC XY: 7AN XY: 133900
GnomAD3 exomes
AF:
AC:
17
AN:
247454
Hom.:
AF XY:
AC XY:
7
AN XY:
133900
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000163 AC: 238AN: 1460272Hom.: 0 Cov.: 36 AF XY: 0.000165 AC XY: 120AN XY: 726162
GnomAD4 exome
AF:
AC:
238
AN:
1460272
Hom.:
Cov.:
36
AF XY:
AC XY:
120
AN XY:
726162
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000921 AC: 14AN: 152054Hom.: 0 Cov.: 33 AF XY: 0.0000942 AC XY: 7AN XY: 74294
GnomAD4 genome
AF:
AC:
14
AN:
152054
Hom.:
Cov.:
33
AF XY:
AC XY:
7
AN XY:
74294
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
3
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
4
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.2362A>C (p.M788L) alteration is located in exon 6 (coding exon 6) of the GPRC6A gene. This alteration results from a A to C substitution at nucleotide position 2362, causing the methionine (M) at amino acid position 788 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Uncertain
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Uncertain
Sift
Benign
T;D;D
Sift4G
Uncertain
D;D;D
Polyphen
B;P;B
Vest4
MutPred
Gain of catalytic residue at M788 (P = 0.0171);.;.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at